Dust removing device with air curtain separation and self-circulation purification

Abstract

The invention discloses a dust removing device with air curtain separation and self-circulation purification, comprising material input transmission cabin (1), main separation cabin (2), material output transmission cabin (3) and a control cabinet (03). The dust removing device adopts the following technical scheme: three independent interlayer separation cabins consist of the main separation cabin, the material input transmission cabin and the material output transmission cabin, a self-circulation purification device formed by arranging a self-circulation air tube with an inserting plate type coarse-efficiency filter and an inserting plate type medium-efficiency filter on the main separation cabin, and split-flow cleaning air curtains formed by inlet split-flow air curtain channels and outlet split-flow air curtain channels are respectively arranged between the main separation cabin and the material input transmission cabin, and between the main separation cabin and the material output transmission cabin. By the modes of air curtain separation and self-circulation purification, dust generated by processing equipment is separated into a dust generating area, and is removed when being generated instantly, so that the cleaning degree of the medicine processing equipment can achieve the standard requirement of Chinese 2010-section GMP (Good Manufacturing Practice).

Description

Technical field [0001] The invention relates to a clean isolation facility for pharmaceutical processing equipment, and specifically refers to a kind of equipment used in a pharmaceutical clean area to avoid pollution and interference of dust and aerosol generated by the pharmaceutical processing equipment in operation on the processing area environment and the entire clean area environment Air curtain isolation and self-circulation purification device to eliminate dust. Background technique [0002] The dust generated by the equipment operating in the clean area of ​​the pharmaceutical company will pollute and interfere with the environment of the processing area and the entire clean area. For example, the capping machine, the capping machine is used to plug or stop the filled filling in the clean area of ​​pharmaceutical production. A device for sealing the drug container after freeze-drying and pressing with aluminum cap or aluminum plastic cap; before the drug container is fi...

AI Technical Summary

Problems solved by technology

[0002] The dust generated by the equipment operating in the clean area of ​​the pharmaceutical company will pollute and interfere with the environment of the processing area and the environment of the entire clean area. Equipment for sealing aluminum caps or aluminum-plastic caps on drug containers after freeze-drying and corking; before capping and sealing of drug containers after filling and corking, the connection relationship between the rubber stopper and the bottle mouth is in a "not completely sealed state", and there is a rubber stopper The possibility of loosening or even jumping plugs. At this time, the capping machine in the capping room will produce a large amount of aluminum chips, glass chips, aerosols and other dust particles that are difficult to detect and float around; The generated dust poses a serious pollution threat to the aseptic environment in the capping room. At the same time, the dust will spread around with the purification and air conditioning system in the entire clean area, causing enlarged pollution to the environment of the entire clean area for pharmaceutical production. , Interfering with the purification air conditioning system in the clean area

[0003] my country's 1998 version of GMP has a "minimum requirement" for crimping of non-terminal sterilized products at level 100,000 (level D); when the drug regulatory department revised the 2010 version of GMP, it clearly stipulated that crimping of non-terminal sterilized products must be It is carried out in the environment of "A level under the background of B level". However, the existing technology cannot meet the requirements of the new version of GMP due to the pollution of aluminum shavings, glass shavings and aerosol to the capping room. Generally, pharmaceutical companies usually put the capping machine in the The operation of the 100-level laminar flow hood in the 100,000-level capping room makes it difficult for the cleanliness of the capping area to meet the standard; in addition to the above-mentioned capping and sealing production links of pharmaceutical production, other production links in pharmaceutical production, such as bacteria and virus species Dust, particles and aerosols will also be produced during the processing and subpackaging of contraceptives, antineoplastic drugs, radioactive chemicals and highly toxic drugs, which will pollute and interfere with the operator and the environment of the entire clean area. Therefore, The existing technology has the problem and deficiency that the cleanliness of the environment in the pharmaceutical processing area is difficult to meet the standard requirements

Images